Intuitively, one would assume that the benefit from the use of thrombolytic therapy in
reducing mortality in acute myocardial infarction (AMI) is directly related to early …

BACKGROUND Experimental and observational clinical studies of acute coronary occlusion
have suggested that late reperfusion prevents infarct expansion and facilitates myocardial …

BACKGROUND A paradoxical increased risk of death has been reported during the first 24
hours after thrombolysis for myocardial infarction. The mechanism of this phenomenon is not …

Outcome after myocardial infarction can be improved by prompt reperfusion of the infarct-
related coronary artery by thrombolysis or by primary angioplasty. Despite the uncertain role …

Outcome after myocardial infarction can be improved by prompt reperfusion of the infarct-
related coronary artery by thrombolysis or by primary angioplasty. Despite the uncertain role …

Thrombolytic therapy for the treatment of acute myocardial infarction (AMI) began more than
15 years ago with the initial observations of Rentrop et al 1 and others 2 that demonstrated …

Time to treatment with thrombolytic therapy has been recognized as an important factor in
the treatment of patients with acute myocardial infarction: By restoring infarct-related artery …

T he salvage of severely ischemic myocardium by means of thrombolytic therapy represents
a major advance in the management of acute myocardial infarction (AMI). Reperfusion was …

The importance of achieving rapid patency of the infarct-related artery during acute
myocardial infarction has become well recognized. Early, sustained patency of the infarct …

OBJECTIVES The study evaluated the efficacy and safety of a short-acting reduced-dose
fibrinolytic regimen to promote early infarct-related artery (IRA) patency during the inherent …